1290625 Ethylenedioxybenzene derivative KALI-CHEMIE AG 4 Jan 1971 [7 Jan 1970] 359/71 Heading C2C The invention comprises the compound of formula its non-toxic acid addition salts, and a method of producing this compound by effecting any of the following reactions in an inert solvent in the presence of a basic condensing agent: (a) substituting the alpha-H atom in alpha-isopropylethylenedioxyphenylacetonitrile ; (b) introduc - ing the isopropyl group into a compound (II) identical with that of the above formula except that the isopropyl group is absent (II is made by substituting the alpha-H atom in ethylenedioxyphenylacetonitrile) ; (c) substituting the NH group in N-methylveratrylmethylamine (III); (d) N-methylating a compound (IV) identical with that of the above formula except that the N- methyl group is absent (IV is made by substituting the NH 2 group in III). Therapeutic compositions for oral or parenteral administration comprise the compound of the above formula, which has a corona-dilating effect.
展开▼
机译：1290625乙二氧基苯衍生物KALI-CHEMIE AG 1971年1月4日[1970年1月7日] 359/71标题C2C本发明包括具有化学式的化合物及其无毒酸加成盐，以及通过在下述条件下进行以下任何反应来制备该化合物的方法：在碱性缩合剂存在下的惰性溶剂：（a）将α-H原子替换为α-异丙基乙二氧基苯基乙腈; （b）将异丙基引入与上式相同的化合物（II）中，不同之处在于不存在异丙基（II是通过在乙二氧基苯基乙腈中取代α-H原子制得的）; （c）将NH基团取代在N-甲基藜芦基甲胺（III）中; （d）对N-甲基化与上式相同的化合物（IV），不同之处在于不存在N-甲基（IV通过用III中的NH 2取代而制得）。口服或肠胃外给药的治疗组合物包含具有电晕扩张作用的上式化合物。
展开▼
